Company / CapEx per Share
Arbutus Biopharma Corp CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
-
FY2025
5-year range
$0.00 / $0.01
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
#188 of 192
Health Care
What the data says
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 192
▼
Key checks
Key Insights
- In FY2025, capex per share decreased 100.0% year-over-year.
- Peak capex per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -100.0% |
| FY2024 | $0.00 | -83.3% |
| FY2023 | $0.01 | +81.3% |
| FY2022 | $0.00 | -60.9% |
| FY2021 | $0.01 | -0.8% |
| FY2020 | $0.01 | -55.6% |
| FY2019 | $0.02 | -84.5% |
| FY2018 | $0.13 | +0.0% |
| FY2017 | $0.13 | +81.1% |
| FY2016 | $0.07 | +73.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026